Our results confirm the contribution of the NLRP3 inflammasome pathway to COVID-19 severity and the ability of VitD3 to attenuate hyperinflammation via downregulating the NLRP3 inflammasome pathway. The gene discussed is NLRP3; the disease is COVID-19.